Antidepressant-Coincident Mania in Children and Adolescents Treated with Selective Serotonin Reuptake Inhibitors

• Kratochvil CJ , VitielloB, WalkupJet al.: Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?J. Child Adolesc. Psychopharmacol.16, 11–24 (2006).
   PubMed Web of Science ®Google Scholar
• Olfson M , MarcusSC, WeissmanMM, JensenPS: National trends in the use of psychotropic medications by children.J. Am. Acad. Child. Adolesc. Psychiatry41, 514–521 (2002).
   PubMed Web of Science ®Google Scholar
• Emslie GJ , HeiligensteinJH, WagnerKDet al.: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.J. Am. Acad. Child Adolesc. Psychiatry41, 1205–1215 (2002).
   PubMed Web of Science ®Google Scholar
• Wagner KD , AmbrosiniP, RynnMet al.: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.JAMA290, 1033–1041 (2003).
   PubMed Web of Science ®Google Scholar
• Michael KD , CrowleySL: How effective are treatments for child and adolescent depression? A meta-analytic review.Clin. Psychol. Rev.22, 247–269 (2002).
   PubMed Web of Science ®Google Scholar
• Usala T , ClavennaA, ZuddasA, BonatiM: Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis.Eur. Neuropsychopharmacol.18, 62–73 (2008).
   PubMed Web of Science ®Google Scholar
• Emslie GJ , WagnerKD, KutcherSet al.: Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.J. Am. Acad. Child Adolesc. Psychiatry45, 709–719 (2006).
   PubMed Web of Science ®Google Scholar
• Renaud J , AxelsonD, BirmaherB: A risk–benefit assessment of pharmacotherapies for clinical depression in children and adolescents.Drug Safety20, 59–75 (1999).
   PubMed Web of Science ®Google Scholar
• Bridge JA , IyengarS, SalaryCBet al.: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.JAMA297, 1683–1696 (2007).
   PubMed Web of Science ®Google Scholar
• Clennell A : Threat of suicide leads to ban of major antidepressants for children. The Independent. 10 December 2003.
   Google Scholar
• Baumer FM , HoweM, GallelliK, SimeonovaDI, HallmayerJ, ChangKD: A pilot study of antidepressant-induced mania in pediatric bipolar disorder: characteristics, risk factors, and the serotonin transporter gene.Biol. Psychiatry60, 1005–1012 (2006).
   PubMed Web of Science ®Google Scholar
• Hellander M : Medication-induced mania: ethical issues and the need for more research.J. Child Adolesc. Psychopharmacol.13, 199 (2003).
   PubMed Web of Science ®Google Scholar
• Carlson GA : The bottom line.J. Child Adolesc. Psychopharmacol.13, 115–118 (2003).
   PubMed Web of Science ®Google Scholar
• Goldberg JF , TrumanCJ: Antidepressant-induced mania: an overview of current controversies.Bipolar Disord.5, 407–420 (2003).
   PubMed Web of Science ®Google Scholar
• Papolos DF : Switching, cycling, and antidepressant-induced effects on cycle frequency and course of illness in adult bipolar disorder: a brief review and commentary.J. Child Adolesc. Psychopharmacol.13, 165–171 (2003).
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS , KarippotA: Use of antidepressants to treat depression in bipolar disorder.Psychiatr. Serv.53, 580–584 (2002).
   PubMed Web of Science ®Google Scholar
• Truman CJ , GoldbergJF, GhaemiSNet al.: Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).J. Clin. Psychiatry68, 1472–1479 (2007).
   PubMed Web of Science ®Google Scholar
• Martin A , YoungC, LeckmanJF, MukonoweshuroC, RosenheckR, LeslieD: Age effects on antidepressant-induced manic conversion.Arch. Pediatr. Adolesc. Med.158, 773–780 (2004).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ , FaeddaGL, HennenJ: Risk of mania with antidepressants.Arch. Pediatr. Adolesc. Med.159, 298; author reply 298–299 (2005).
   PubMedGoogle Scholar
• Altshuler LL , PostRM, LeverichGS, MikalauskasK, RosoffA, AckermanL: Antidepressant-induced mania and cycle acceleration: a controversy revisited.Am. J. Psychiatry152, 1130–1138 (1995).
   PubMed Web of Science ®Google Scholar
• Davidow J , LevinsonEM: Heuristic principles and cognitive bias in decision making: implications for assessment in school psychology.Psychol. Sch.30, 351–361 (1993).
   Web of Science ®Google Scholar
• Blader JC , CarlsonGA: Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996–2004.Biol. Psychiatry62, 107–114 (2007).
   PubMed Web of Science ®Google Scholar
• Moreno C , LajeG, BlancoC, JiangH, SchmidtAB, OlfsonM: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.Arch. Gen. Psychiatry64, 1032–1039 (2007).
   PubMed Web of Science ®Google Scholar
• Reichart CG , NolenWA: Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis.J. Affect. Disord.78, 81–84 (2004).
   PubMed Web of Science ®Google Scholar
• Spraggs C , McCarthyA, McCarthyLet al.: Genetic variants in the epithelial sodium channel associate with oedema in Type 2 diabetic patients receiving the peroxisome proliferator-activated receptor g agonist farglitazar.Pharmacogenet. Genomics17, 1065–1076 (2007).
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders (4th Text Revision Edition). American Psychiatric Association, Washington, DC, USA 886 (2001).
   Google Scholar
• Kraemer HC , LoweKK, KupferDJ: To Your Health: How to Understand What Research Tells Us About Risk. Oxford University Press, NY, USA 288 (2005).
   Google Scholar
• Straus SE , RichardsonWS, GlasziouP, HaynesRB: Evidence-Based Medicine: How to Practice and Teach EBM (3rd Edition). Churchill Livingstone, NY, USA (2005).
   Google Scholar
• Garb HN : Studying the Clinician: Judgment Research and Psychological Assessment. American Psychological Association, Washington, DC, USA (1998).
   Google Scholar
• Emslie G , KratochvilC, VitielloBet al.: Treatment for Adolescents with Depression Study (TADS): safety results.J. Am. Acad. Child Adolesc. Psychiatry45, 1440–1455 (2006).
   PubMed Web of Science ®Google Scholar
• Brent D , EmslieG, ClarkeGet al.: Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.JAMA299, 901–913 (2008).
   PubMed Web of Science ®Google Scholar
• Campbell DT , StanleyJC: Experimental and Quasi-Experimental Designs for Research. Houghton Mifflin, MA, USA 84 (1963).
   Google Scholar
• Moher D , SchulzKF, AltmanDG: The CONSORT statement: revised recommendations for improving the quality of reports of parellel-group randomised trials.Lancet357, 1191–1194 (2001).
   PubMed Web of Science ®Google Scholar
• Merikangas KR , HerrellR, SwendsenJ, RosslerW, Ajdacic-GrossV, AngstJ: Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.Arch. Gen. Psychiatry65, 47–52 (2008).
   PubMed Web of Science ®Google Scholar
• Dubicka B , CarlsonGA, VailA, HarringtonR: Prepubertal mania: diagnostic differences between US and UK clinicians.Eur. Child Adolesc. Psychiatry17, 153–161 (2008).
   PubMed Web of Science ®Google Scholar
• Healy D : The latest mania: selling bipolar disorder.PLoS Medicine3, E185 (2006).
   PubMed Web of Science ®Google Scholar
• Biederman J , MickE, FaraoneSV, SpencerT, WilensTE, WozniakJ: Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder.Int. J. Neuropsychopharmacol.6, 293–300 (2003).
   PubMed Web of Science ®Google Scholar
• Geller B , TillmanR: Prepubertal and early adolescent bipolar disorder I: review of diagnostic validation by Robins and Guze criteria.J. Clin. Psychiatry66(Suppl. 7), 21–28 (2005).
   PubMedGoogle Scholar
• Youngstrom EA , BirmaherB, FindlingRL: Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis.Bipolar Disord.10, 194–214 (2008).
   PubMed Web of Science ®Google Scholar
• Birmaher B , RyanND, WilliamsonDEet al.: Childhood and adolescent depression: a review of the past 10 years. Part I.J. Am. Acad. Child Adolesc. Psychiatry35, 1427–1439 (1996).
   PubMed Web of Science ®Google Scholar
• Geller B , ZimermanB, WilliamsM, BolhofnerK, CraneyJL: Bipolar disorder at prospective follow-up of adults who had prepubertal major Depressive disorder.Am. J. Psychiatry158, 125–127 (2001).
   PubMed Web of Science ®Google Scholar
• Lish JD , Dime-MeenanS, WhybrowPC, PriceRA, HirschfeldRM: The National Depressive and Manic–Depressive Association (DMDA) survey of bipolar members.J. Affect. Disord.31, 281–294 (1994).
   PubMed Web of Science ®Google Scholar
• Goodwin FK , JamisonKR: Manic–Depressive Illness (2nd Edition). Oxford University Press, NY, USA 1262 (2007).
   Google Scholar
• Perlis RH , BrownE, BakerRW, NierenbergAA: Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.Am. J. Psychiatry163, 225–231 (2006).
   PubMed Web of Science ®Google Scholar
• Guyatt GH , RennieD (Eds): Users‘ Guides to the Medical Literature. AMA Press, IL, USA 706 (2002).
   Google Scholar
• Peet M : Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.Br. J. Psychiatry164, 549–550 (1994).
   PubMed Web of Science ®Google Scholar
• Henry C , SorbaraF, LacosteJ, GindreC, LeboyerM: Antidepressant-induced mania in bipolar patients: identification of risk factors.Clin. Psychiatry62, 249–255 (2001).
   PubMed Web of Science ®Google Scholar
• Ghaemi SN , BoimanEE, GoodwinFK: Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study.J. Clin. Psychiatry61, 804–808; quiz 809 (2000).
   PubMed Web of Science ®Google Scholar
• Birmaher B , AxelsonD, StroberMet al.: Clinical course of children and adolescents with bipolar spectrum disorders.Arch. Gen. Psychiatry63, 175–183 (2006).
   PubMed Web of Science ®Google Scholar
• Post RM : The impact of bipolar depression.J. Clin. Psychiatry66(Suppl. 5), 5–10 (2005).
   PubMedGoogle Scholar
• Hirschfeld RM : Bipolar depression: the real challenge.Eur. Neuropsychopharmacol.14(Suppl. 2), S83–S88 (2004).
   PubMedGoogle Scholar
• Findling RL , ReedMD, BlumerJL: Pharmacological treatment of depression in children and adolescents.Paediatr. Drugs1, 161–182 (1999).
   PubMedGoogle Scholar
• Ameen S , JagadheesanK, SinhaVK: Citalopram-induced manic switch in an adolescent with epilepsy.Aust. NZ J. Psychiatry37, 776–777 (2003).
   PubMed Web of Science ®Google Scholar
• Pravin D , SrinathS, GirimajiS, SeshadriSP: Citalopram and mania.J. Am. Acad. Child Adolesc. Psychiatry43, 791 (2004).
   PubMed Web of Science ®Google Scholar
• Achamallah NS , DeckerDH: Mania induced by fluoxetine in an adolescent patient.Am. J. Psychiatry148, 1404 (1991).
   PubMed Web of Science ®Google Scholar
• Jafri AB , GreenbergWM: Fluoxetine side effects.J. Am. Acad. Child Adolesc. Psychiatry30, 852 (1991).
   PubMed Web of Science ®Google Scholar
• Venkataraman S , NaylorMW, KingCA: Mania associated with fluoxetine treatment in adolescents.J. Am. Acad. Child Adolesc. Psychiatry31, 276–281 (1992).
   PubMed Web of Science ®Google Scholar
• Jerome L : Hypomania with fluoxetine.J. Am. Acad. Child Adolesc. Psychiatry30, 850–851 (1991).
   PubMed Web of Science ®Google Scholar
• Go FS , MalleyEE, BirmaherB, RosenbergDR: Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive–compulsive disorder.J. Child Adolesc. Psychopharmacol.8, 73–80 (1998).
   PubMed Web of Science ®Google Scholar
• Diler RS , AvciA: SSRI-induced mania in obsessive–compulsive disorder.J. Am. Acad. Child Adolesc. Psychiatry38, 6–7 (1999).
   PubMed Web of Science ®Google Scholar
• Grubbs JH : SSRI-induced mania.J. Am. Acad. Child Adolesc. Psychiatry36, 445 (1997).
   PubMed Web of Science ®Google Scholar
• Oldroyd J : Paroxetine-induced mania.J. Am. Acad. Child Adolesc. Psychiatry36, 721–722 (1997).
   PubMed Web of Science ®Google Scholar
• Sharkey L , O‘DonovanA: Paroxetine induced mania in pre-adolescence.Ir. J. Psychol. Med.21, 30–31 (2004).
   PubMedGoogle Scholar
• Ghaziuddin M : Mania induced by sertraline in a prepubertal child.Am. J. Psychiatry151, 944 (1994).
   PubMed Web of Science ®Google Scholar
• Heimann SW , MarchJS: SSRI-induced mania.J. Am. Acad. Child Adolesc. Psychiatry35, 4 (1996).
   PubMed Web of Science ®Google Scholar
• Kat H : More on SSRI-induced mania.J. Am. Acad. Child Adolesc. Psychiatry35, 975 (1996).
   PubMed Web of Science ®Google Scholar
• James AC : Case report: Mixed mania – Apparent induction in an adolescent by a selective serotonin reuptake inhibitor antidepressant (SSRI).Clin. Child Psychol. Psychiatry1, 621–624 (1996).
   Google Scholar
• Raman RP , MathSB, GangadharBN: Venlafaxine-induced manic switch in an adolescent patient: a case report.Prim. Care Companion J. Clin. Psychiatry9, 470 (2007).
   PubMedGoogle Scholar
• Gigerenzer G : The adaptive toolbox: toward a darwinian rationality.Nebr. Symp. Motiv.47, 113–143 (2001).
   PubMedGoogle Scholar
• Faedda GL , BaldessariniRJ, GlovinskyIP, AustinNB: Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review.J. Affect. Disord.82, 149–158 (2004).
   PubMed Web of Science ®Google Scholar
• Biederman J , MickE, SpencerTJ, WilensTE, FaraoneSV: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young.J. Child Adolesc. Psychopharmacol.10, 185–192 (2000).
   PubMed Web of Science ®Google Scholar
• Wilens TE , BiedermanJ, KwonAet al.: A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors.J. Child Adolesc. Psychopharmacol.13, 143–152 (2003).
   PubMed Web of Science ®Google Scholar
• Cicero D , El-MallakhRS, HolmanJ, RobertsonJ: Antidepressant exposure in bipolar children.Psychiatry66, 317–322 (2003).
   PubMed Web of Science ®Google Scholar
• Carlson GA , MickE: Drug induced disinhibition in psychiatrically hospitalized children.J. Child Adolesc. Psychopharmacol.13, 153–163 (2003).
   PubMed Web of Science ®Google Scholar
• DelBello MP , HansemanD, AdlerCM, FleckDE, StrakowskiSM: Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode.Am. J. Psychiatry164, 582–590 (2007).
   PubMed Web of Science ®Google Scholar
• Pagano ME , DemeterCA, FaberJE, CalabreseJR, FindlingRL: Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder.Bipolar Disord.10, 334–341 (2008).
   PubMed Web of Science ®Google Scholar
• Soutullo CA , DelBelloMP, OchsnerJEet al.: Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment.J. Affect. Disord.70, 323–327 (2002).
   PubMed Web of Science ®Google Scholar
• DelBello MP , CarlsonG, TohenM, BrometEJ, SchwiersML, StrakowskiSM: Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features.J. Child Adolesc. Psychopharmacol.13, 173–185 (2003).
   PubMed Web of Science ®Google Scholar
• Tillman R , GellerB: Controlled study of switching from attention-deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors.Dev. Psychopathol.18, 1037–1053 (2006).
   PubMed Web of Science ®Google Scholar
• Wagner KD , RobbAS, FindlingRL, JinJ, GutierrezMM, HeydornWE: A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents.Am. J. Psychiatry161, 1079–1083 (2004).
   PubMed Web of Science ®Google Scholar
• Shirazi E , Alaghband-RadJ: An open trial of citalopram in children and adolescents with depression.J. Child Adolesc. Psychopharmacol.15, 233–239 (2005).
   PubMed Web of Science ®Google Scholar
• Wagner KD , JonasJ, FindlingRL, VenturaD, SaikaliK: A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.J. Am. Acad. Child Adolesc. Psychiatry45, 280–288 (2006).
   PubMed Web of Science ®Google Scholar
• Emslie GJ , RushAJ, WeinbergWAet al.: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.Arch. Gen. Psychiatry54, 1031–1037 (1997).
   PubMed Web of Science ®Google Scholar
• Emslie GJ , HeiligensteinJH, HoogSLet al.: Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.J. Am. Acad. Child Adolesc. Psychiatry43, 1397–1405 (2004).
   PubMed Web of Science ®Google Scholar
• Walkup J , LabellarteM, RiddleMAet al.: Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.J. Child Adolesc. Psychopharmacol.12, 175–188 (2002).
   PubMed Web of Science ®Google Scholar
• Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N. Engl. J. Med.344, 1279–1285 (2001).
   PubMed Web of Science ®Google Scholar
• McConville BJ , MinneryKL, SorterMT, WestSA, FriedmanLM, ChristianK: An open study of the effects of sertraline on adolescent major depression.J. Child Adolesc. Psychopharmacol.6, 41–51 (1996).
   PubMed Web of Science ®Google Scholar
• March JS , BiedermanJ, WolkowRet al.: Sertraline in children and adolescents with obsessive–compulsive disorder: a multicenter randomized controlled trial.JAMA280, 1752–1756 (1998).
   PubMed Web of Science ®Google Scholar
• Cook EH , WagnerKD, MarchJSet al.: Long-term sertraline treatment of children and adolescents with obsessive–compulsive disorder.J. Am. Acad. Child Adolesc. Psychiatry40, 1175–1181 (2001).
   PubMed Web of Science ®Google Scholar
• Cheung AH , EmslieGJ, MayesTL: Review of the efficacy and safety of antidepressants in youth depression.J. Child Psychol. Psychiatry46, 735–754 (2005).
   PubMed Web of Science ®Google Scholar
• Freeman AJ , YoungstromEA, MichalakEE, SiegelR, MeyersOI, FindlingRL: Quality of life in pediatric bipolar disorder.Pediatrics (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Wozniak J , BiedermanJ, KwonAet al.: How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates.Biol. Psychiatry58, 583–588 (2005).
   PubMed Web of Science ®Google Scholar
• March JS , EntusahAR, RynnM, AlbanoAM, TourianKA: A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.Biol. Psychiatry62, 1149–1154 (2007).
   PubMed Web of Science ®Google Scholar
• March JS , FranklinME, LeonardHet al.: Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive–compulsive disorder.Biol. Psychiatry61, 344–347 (2007).
   PubMed Web of Science ®Google Scholar
• Youngstrom E , MashEJ, BarkleyRA: Pediatric bipolar disorder. In: Assessment of Childhood Disorders (4th Edition). Guilford Press, NY, USA253–304 (2007).
   Google Scholar
• Mrazek DA : Current applications of clinical genetic testing for psychiatric practice.Minn. Med.90, 42–43 (2007).
   PubMedGoogle Scholar
• Weller EB , WellerRA: Fluoxetine to prevent relapse of depression in children and adolescents.Curr. Psychiatry Rep.8, 88–89 (2006).
   PubMedGoogle Scholar

Websites

• Class suicidality labeling language for antidepressants. www.fda.gov/Cder/drug/antidepressants/PI_template.pdf (Accessed 27July2008).
   Google Scholar
• Waters R: Johnny get your pills: are we overmedicating our kids? (1999). http://dir.salon.com/story/health/feature/1999/06/17/antidepressants
   Google Scholar